Ascendis Pharma As Stock Price on September 12, 2022
| ASND Stock | USD 144.83 2.73 1.92% |
Below is the normalized historical share price chart for Ascendis Pharma AS extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ascendis Pharma stands at 144.83, as last reported on the 24th of April, with the highest price reaching 147.45 and the lowest price hitting 143.30 during the day.
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. We consider Ascendis Pharma very steady. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of 0.0761, which signifies that the company had a 0.0761% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Ascendis Pharma AS, which you can use to evaluate the volatility of the firm. Please confirm Ascendis Pharma's mean deviation of 1.68, and Risk Adjusted Performance of 0.0523 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%.
At present, Ascendis Pharma's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 70 M, whereas Common Stock Total Equity is forecasted to decline to about 4.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.79, whereas Price To Sales Ratio is forecasted to decline to 22.84. Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of January 2015 | 200 Day MA 115.1239 | 50 Day MA 148.7594 | Beta 0.51 |
Ascendis |
Sharpe Ratio = 0.0761
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average Ascendis Pharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding it to a well-diversified portfolio.
Price Book 14.5547 | Enterprise Value Ebitda (20.75) | Price Sales 30.9989 | Shares Float 56.2 M | Wall Street Target Price 0.34 |
Ascendis Pharma Valuation on September 12, 2022
It is possible to determine the worth of Ascendis Pharma on a given historical date. On September 12, 2022 Ascendis was worth 102.16 at the beginning of the trading date compared to the closed value of 103.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascendis Pharma stock. Still, in general, we apply an absolute valuation method to find Ascendis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascendis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascendis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 101.84 | 104.20 | 100.47 | 101.38 | 356,900 | |
09/12/2022 | 102.16 | 105.28 | 100.35 | 103.61 | 348,100 |
| 101.23 | 103.04 | 100.28 | 102.70 | 368,500 |
| Backtest Ascendis Pharma | | | Ascendis Pharma History | | | Ascendis Pharma Valuation | Previous | Next |
Ascendis Pharma Trading Date Momentum on September 12, 2022
| On September 13 2022 Ascendis Pharma AS was traded for 102.70 at the closing time. The top price for the day was 103.04 and the lowest listed price was 100.28 . The trading volume for the day was 368.5 K. The trading history from September 13, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.88% . The overall trading delta against the current closing price is 2.83% . |
Ascendis Pharma AS Fundamentals Correlations and Trends
By evaluating Ascendis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascendis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascendis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.3 M | 39.2 M | |
| Net Loss | -524.9 M | -498.6 M |
Ascendis Pharma Quarterly Net Working Capital |
|
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ascendis Pharma Period Price Range
Low | September 12, 2022
| High |
102.16 | 103.61 |
Ascendis Pharma April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns
| Accumulation Distribution | 16300.66 | |||
| Daily Balance Of Power | 0.2941 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 102.82 | |||
| Day Typical Price | 103.08 | |||
| Price Action Indicator | 1.52 | |||
| Period Momentum Indicator | 41.22 |
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0523 | |||
| Jensen Alpha | 0.0559 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0345 | |||
| Treynor Ratio | 0.1329 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Ascendis Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.11) | Revenue Per Share 4.739 | Quarterly Revenue Growth 5.014 | Return On Assets (0.30) | Return On Equity (8.18) |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.